OBJECTIVE: The aim of this study was to analyse the feasibility and determine the benefits of MRI-based pre-planning with CT/MRI data fusion in patients with cervical cancer treated with radical radiotherapy. METHODS: Patients underwent MRI examination prior to external beam radiotherapy and prior to the first and fourth fraction of brachytherapy with applicators in place. Insertion of applicators at the radiology department was performed under paracervical anaesthesia. The benefit of MRI pre-planning was determined by comparing conventional treatment planning with dose specification to "point A" and dose specification to 90% of the high-risk clinical target volume (HR-CTV D90). Tolerance of MRI evaluation with applicators, coverage of HR-CTV and dose-volume parameters for organs at risk (OAR) has been assessed in 42 brachytherapy procedures. RESULTS: Insertion of applicators at the radiology department was successful in all patients and there were no complications. The target dose was higher for MRI planning than for conventional planning (5.3 Gy vs 4.5 Gy). Maximum doses in the bladder and rectum were significantly lower (p<0.05) for MRI planning than for the conventional approach (6.49 Gy vs 7.45 Gy for bladder; 4.57 Gy vs 5.06 Gy for rectum). We found no correlation between the International Commission on Radiation Units (ICRU) point dose for OAR and the maximum dose in OAR. Nevertheless, a strong correlation between the maximum dose in OAR and the minimal dose in a volume of 2 cm(3) has been observed. CONCLUSION: MRI-based pre-planning with consecutive CT/MRI data fusion is feasible and safe, with the advantage of increasing the dose to the tumour and decreasing the dose to the organs at risk.

Oncology Centre Pardubice Regional Hospital Pardubice Czech Republic

Zobrazit více v PubMed

Thirion P, Kelly C, Salib O, Moriarty M, O'Reilly D, Griffin M, et al. A randomised comparison of two brachytherapy devices for the treatment of uterine cervical carcinoma. Radiother Oncol 2005;74:247–50 PubMed

Pötter R, Dimopoulos J, Bachtiary B, Sissolak G, Klos B, Rheinthaller A, et al. 3D-conformal HDR brachytherapy and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: Clinical experience with 3 year follow up. Radiother Oncol 2006;79:80–86 PubMed

Fellner C, Potter R, Knocke TH, Wambersie A. Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. Radiother Oncol 2001;58:53–62 PubMed

Pötter R, Knocke TH, Fellner C, Baldass M, Reinthaller A, Kucera H. Definitive radiotherapy based on HDRbrachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993–1997) compared to the preceding period in the context of ICRU 38 recommendations. Cancer Radiother 2000;4:159–72 PubMed

Dimopoulos JCA, Schard G, Berger D, Lang S, Goldner G, Helbich T, et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: Potential of MRI on delineation of target, pathoanatomic structures, and organs at risk. Int J Radiat Oncol Biol Phys 2006;64:1380–1388 PubMed

Dimopoulos JC, Schirl G, Baldinger A, Helbich TH, Pötter R. MRI assessment of cervical cancer for adaptive radiotherapy. Strahlenther Onkol 2009;185:282–7 PubMed

Pötter R, Fidarova E, Kirisits C, Dimopoulos J. Image-guided adaptive brachytherapy for cervix carcinoma. Clin Oncol 2008;20:426–432 PubMed

Lang S, Nulens A, Briot E, Kirisits C, De Brabandere M, Dumas I, et al. Comparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations. Radiother Oncol 2006;78:185–193 PubMed

Haie-Meder C, Chargari C, Rey A, Dumas I, Morice P, Magne N. DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery. Radiother Oncol 2009;93:316–21 PubMed

De Brabandere M, Mousa AG, Nulens A, Swinnen A, Van Limbergen E. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol 2008;88:217–26 PubMed

Haie-Meder C, Pötter R, van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from the Gynaecological (GYN) GEC ESTRO Working Group: Concepts and terms in 3D-image based 3D-treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2004;74:235–45 PubMed

Pötter R, Haie-Meder C, van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose-volume parameters and aspects of 3D-image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006;78:67–77 PubMed

Dimopoulos J, De Vos V, Berger D, Petric P, Dumas I, Kirisits C, et al. Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations. Radiother Oncol 2009;91:166–72 PubMed

Petric P, Dimopoulos J, Kirisits C, Berger D, Hudej R, Pötter R. Inter- and intraobserver variation in HR-CTV contouring: intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy. Radiother Oncol 2008;89:164–71 PubMed

Pötter R, Dimopoulos J, Georg P, Lang S, Waldhäusl C, Wachter-Gerstner N, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007;83:148–55 PubMed

Dimopoulos JCA, Lang S, Kirisits C, Fidarova EF, Berger D, Georg P, et al. Dose–volume histogram parameters and local tumor control in MR image guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 2009;75:56–63 PubMed

Kirisits C, Pötter R, Lang S, Dimopoulos J, Wachter-Gerstner N, Georg D. Dose and volume parameters for MRI based treatment planning in intracavitary brachytherapy of cervix cancer. Int J Radiat Oncol Biol Phys 2005;62:901–11 PubMed

Berger D, Dimopoulos J, Potter R, Kirisits C. Direct reconstruction of the Vienna applicator on MRI images. Radiother Oncol 2009;93:347–51 PubMed

Kirisits C, Trnkova P, Baltas D, Dimopoulos J, Potter R. Inverse optimization for cervix cancer brachytherapy including automatic loading, DVH optimization and modification restriction adapted from manual planning. Med Phys 2008;35:2726

Berger D, Dimopoulos J, Georg P, Georg D, Pötter R, Kirisits C. Uncertainties in assessment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator. Int J Radiat Oncol Biol Phys 2007;67:1451–9 PubMed

Lang S, Kirisits C, Dimopoulos J, Georg D, Pötter R. Treatment planning for MRI assisted brachytherapy of gynaecological malignancies based on total dose constraints. Int J Radiat Oncol Biol Phys 2007;69:619–27 PubMed

Haack S, Nielsen SK, Lindegaard JC, Gelineck J, Tanderup K. Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer. Radiother Oncol 2009;91:187–93 PubMed

Tanderup K, Hellebust TP, Lang S, Granfeldt J, Pötter R, Lindegaard JC, et al. Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer. Radiother Oncol 2008;89:156–63 PubMed

Sun LM, Huang HY, Huang EY, Wang CJ, Ko SF, Lin H, et al. A prospective study to assess the bladder distension effects on dosimetry in intracavitary brachytherapy of cervical cancer via computed tomography-assisted techniques. Radiother Oncol 2005;77:77–82 PubMed

Muschitz S, Petrow P, Briot E, Petit C, Crevoisier R, Duvillard P, et al. Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma. Radiother Oncol 2004;73:187–94 PubMed

Sun LM, Huang EY, Ko SF, Wang CJ, Leung SW, Lin H, et al. Computer tomography-assisted three-dimensional technique to assess rectal and bladder wall dose in intracavitary brachytherapy for uterine cervical cancer. Radiother Oncol 2004;71:333–7 PubMed

Yang WT, Walkden SB, Ho S, Cheung TH, Lam SK, Teo J, et al. Transrectal ultrasound in the evaluation of cervical carcinoma and comparison with spiral computed tomography and magnetic resonance imaging. Br J Radiol 1996;69:610–16 PubMed

Reznek RH, Sahdev A. MR imaging in cervical cancer: seeing is believing: the 2004 Mackenzie Davidson Memorial Lecture. Br J Radiol 200578:S73–85S PubMed

Jena A, Oberoi R, Rawal S, Das SK, Pandey KK. Parametrial invasion in carcinoma of cervix: role of MRI measured tumour volume. Br J Radiol 200578:1075–7 PubMed

Prolonged treatment planning can increase real rectal dose in 3D brachytherapy for cervical cancer

Dosimetric comparison of MRI-based HDR brachytherapy and stereotactic radiotherapy in patients with advanced cervical cancer: A virtual brachytherapy study